Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1150 of 2406 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 08/31/03
End: 08/31/06
Due: 08/31/07
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 01/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 04/30/25
End: 03/27/26
Due: 03/27/27
Phase: N/A
Priority: Normal
Start: 06/30/04
End: 04/30/05
Due: 04/30/06
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 04/08/18
End: 03/08/19
Due: 03/08/20
Phase: N/A
Priority: Normal
Start: 04/11/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 11/05/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 02/25/19
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 04/15/24
End: 04/15/27
Due: 04/15/28
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 08/02/19
End: 10/26/23
Due: 10/26/24
Phase: N/A
Priority: Normal
Start: 09/16/21
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 06/30/16
Due: 06/30/17
Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 08/14/19
End: 11/12/22
Due: 11/12/23
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 05/31/10
End: -
Due: -